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Summary.-Cytoplasts and karyoplasts were obtained by ultracentrifugation of
Hepatoma D23 cells on a Ficoll gradient containing cytochalasin B. Their nuclear and
protein content and their metabolic activity were determined. Three i.p. injections
of2*3 x 107 cytoplasts were unable to protect syngeneic WAB/Not rats against an s.c.
challenge of 104 D23 cells, whereas a similar amount of karyoplasts, or 3 injections of
106 irradiated D23 cells, were fully protective. Ability of cytoplasts to act as primary
or secondary immunogen was also studied, and compared to that of 0.01% glutar-
aldehyde-treated cells, 43°C heat-treated cells and 3M KCl-soluble extracts, these
preparations also being of weak immunogenicity. Only heat-treated cells behaved
as a primary immunogen, whereas none of the preparations provided a secondary
stimulation. Moreover, when these preparations were fed in vitro to peritoneal-
exudate cells before their injection into rats, cytoplasts and glutaraldehyde-treated
cells showed no immunogenicity, whereas heat-treated cells induced full protection
against tumour challenge. Therefore, in this tumour model, the in vivo persistence
of immunogen and the presence of a nucleus are likely to be crucial in inducing
transplantation resistance to tumour.
STUDIES ON THE IMMUNOGENICITY of
syngeneic tumours have been performed
mainly with whole tumour cells, more or
less modified by chemical or physical
treatment, or with subcellular fractions
such as plasma membranes or soluble
antigenic extracts (Mathe, 1971). Most
of the results have indicated that intact
tumour cells inactivated by irradiation or
mitomycin C were usually the best
immunogen, and that plasma membranes
or soluble antigenic extracts were less
immunogenic (Law et al., 1980) or non-
immunogenic in weakly immunogenic
tumour models (Price et al., 1978). More-
over, in the latter study, results obtained
on the influence of chemical (glutaralde-
hyde fixation) or physical treatment
(heating) suggested that the degree of
immunogenicity of the cell preparation
could be related to the level ofthe residual
metabolic activity (Dennick et al., 1979).
In order to evaluate this point, we have
investigated the immunogenicity of enu-
cleated cell preparations, since it has been
demonstrated that such cytoplast and
karyoplast preparations retained some
degree of metabolic activity (Wigler &
Weinstein, 1975) and cell-surface antigen
expression (Berke & Fishelson, 1976;
Hale & Paulus, 1979).
The mass enucleation procedure was
derived from the technique previously
described by Wigler & Weinstein (1975).
The tumour used in these experiments was
the hepatoma D23 initially induced by
4-dimethylaminoazobenzene in a WAB/
Not rat. This tumour has been demonstra-
ted to be immunogenic since injections of
irradiated viable tumour cells protected
the syngeneic rats against a challenge
with a low number of cells (Baldwin &
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Barker, 1967). The immunogenicity was
weak, however, and no transplantation
immunity was observed with soluble anti-
gens (Price et al., 1978) or cells treated
with 0.01% glutaraldehyde (Price et al.,
1979) or heating to 43°C and above
(Dennick et al., 1979).
It is reported here that tumour karyo-
plasts were able to induce transplantation
immunity, whereas cytoplasts lacked this
property. The ability of the cytoplasts
to act as a primary or a secondary immu-
nogen was also tested, and compared with
that of glutaraldehyde- or heat-treated
cells and with 3M KCI soluble extracts of
Hepatoma D23.
MATERIAL AND METHODS
Animals.-Eight- to 10-week-old male
WAB/Not rats were used in these experi-
ments.
Tumour.-The rat hepatoma D23 (Baldwin
& Barker, 1967) and its ascites subline were
maintained by s.c. or i.p. transplantation in
syngeneic WAB/Not rats (Robins, 1975).
Enucleation procedure.-D23 ascites cells
were enucleated as described by Wigler &
Weinstein (1975), with minor modifications.
Briefly, 4 x 107 D23 cells were washed x 3 in
Dulbecco phosphate-buffered saline (DPBS)
treated for 10 min in DPBS containing 0-2
g/l EDTA (Sigma Chemical Co., St Louis, Mo)
and resuspended in 3 ml of 11% Ficoll
(Pharmacia Fine Chemical, Uppsala, Sweden)
in Hepes Eagle minimal essential medium
HEMEM) (Grand Island Biological Co.,
Grand Island, N.Y.) containing 10 ,tg/ml
cytochalasin B (Sigma) and carefully layered
on a 37°C prewarmed Ficoll gradient con-
sisting of2 ml each of25%, 17%, 15%, 13X5%
and 12.5% Ficoll in HEMEM containing
10 ,ug cytochalasin B in 16-5ml MSE ultra-
centrifuge tubes (MSE, Crawley). A final
layer of2 ml ofHEMEM containing 10 jug/ml
cytochalasin B was added, and the gradient
was ultracentrifuged at 35°C for 90 min at
23,500 rev/min on a 6 x 16-5ml MSE Alu-
minium Rotor.
The 0-11% and 11-12.5% interfaces con-
tained enucleated cells (cytoplasts) and the
17-25% interface contained mainly the
karyoplasts. Cytoplasts and karyoplasts were
washed x 2 in a large excess of medium and
incubated 40 min at 37°C to allow them to
recover from the cytochalasin B, and finally
pelleted at 600 g for 5 min before final resus-
pension. Both fractions were analysed for the
number of particles excluding trypan blue,
nuclei content (Feulgen staining) and protein
content (Lowry). Density of these particles
was determined by equilibration on a con-
tinuous isotonic Percoll gradient (Pharmacia)
made by ultracentrifugation for 20 min at
20,000 g on an angular 50 Ti rotor (Beckman
Instruments Ltd, Fife) or either 40% or 60%
Percoll in HEMEM. The gradients were
graduated with coloured beads of known
density (Pharmacia). Metabolic activity of
the subcellular particles was determined by a
short-term incorporation of [3H]-leucine or
[3H]dT. 5 x 106 cells (or particles) were incu-
bated for 1 h at 37°C in 0 5 ml of HEMEM
containing 10% foetal calf serum (Grand
Island Biological Co.) and 20 jtCi of [3H]dT
(20-50 mCi/mmol, Radiochemical Centre,
Amersham) or in 0 5 ml of leucine-free MEM
(Gibco) containing 10% foetal calfserum and
20 ,Ci of 3H-L-leucine (40-60 Ci/mmol,
Radiochemical Centre, Amersham). After 3
washes, the cells were disrupted in 1% SDS
(Sigma) for 10 min and the DNA and protein
were precipitated in 10% TCA (Sigma) for 30
min. After centrifugation the pellet was
washed once more with 10%// TCA and finally
dissolved in 0 5 ml 20g/1Na2CO3, 01N NaOH;
0-1 ml of the solution was added to 1 ml of
scintillation liquid and the radioactivity was
measured in a Packard liquid scintillation
spectrometer. The number of contaminating
tumorigenic whole cells in the cytoplast and
karyoplast fractions was determined by their
ability to induce ascites in WAB/Not rats
after i.p. injections of serial dilutions; the
results observed (median survival time) was
compared with that of rats similarly injected
with 104, 103 or 102 untreated D23 cells.
Tumour-rejection assay.-Groups of 6 rats
were immunized x 3 by weekly i.p. injections
with the various cell and subcellular prepara-
tions previously irradiated with 150 Gy using
a lOOOCi 60Co source. Rats were challenged
1 week later by s.c. injection of 104 D23
tumour-derived cells prepared by trypsin
treatment as previously described (Baldwin
& Barker, 1967). To study the ability of
various cell preparations (cytoplasts, glutar-
aldehyde- or heat-treated cells, 3M KCl-
soluble extracts) to act as a subthreshold
primary or secondary immunogen, the im-
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munization procedure was modified as fol-
lows: rats were immunized i.p. either x 2
with one of the test preparations followed by
an injection of 106 untreated irradiated D23
cells, or x 1 with 106 untreated irradiated
D23 cells followed by 2 injections of the test
preparations. Glutaraldehyde (0.01%) and
43°C heat treatment of irradiated D23 cells
were performed as previously described
(Dennick et al., 1979; Price et al., 1979) and
soluble KCI-3M extract of D23 was prepared
as previously reported (Price et al., 1978). For
the feeding of peritoneal-exudate cells (PEC)
with the various cell preparations and their
transfer to syngeneic rats, the procedure was
as follows: PEC were obtained by aspirating
the peritoneal cavity with cold DPBS con-
taining 5 u/ml heparin of rats injected i.p.
with autoclaved paraffin oil4days previously.
The PEC were further washed x 3 at 4°C.
4 x 107 PEC were incubated with the various
cell preparations for 1 h at 37°C in DPBS.
Before the i.p. injection in rats, PEC and
immunogen were pelleted by 400g centrifuga-
tion for 5 min and resuspended in DPBS. The
rats were challenged s.c. 1 week later with
1_04 tumour-derived D23 cells. The index for
tumour growth is expressed as immuno-
genicity index as defined by Law et al. (1980).
This represents the mean tumour volume of
the non-immunized control group, divided by
the mean tumour volume of immunogen-
inoculated rats. The mean tumour volume of
each group of rats expressed in mm3 is the
arithmetic mean of the tumour volumes of
the group. Tumour volume was determined
by the formula (Attia et al., 1965) 1 x d2 x 0-4,
where 1 is the largest diameter and d the
smallest.
RESULTS
Characterization of cytoplasts and
karyoplasts (summarized in Table I)
From 4 x 107 D23 cells applied on the
Ficoll gradient 2-8 x 107 + 1-2 cytoplasts
and 1-6 x 107 + 0-57 karyoplasts were re-
covered. More than 95% of the cytoplasts
and 60-90% of the karyoplasts retained
selective membrane permeability, as de-
termined by their ability to exclude trypan
blue. As determined after Feulgen stain-
ing, the cytoplastswere contaminatedwith
less than 1% nucleated particles and
>90% of the "karyoplasts" were nuclea-
ted, which was confirmed by electron
microscopy. The cytoplasts consisted of
cytoplasmic fragments surrounded by
plasma membrane and containing the
usual cytoplasmic organelles, and the
karyoplast preparation contained mainly
nuclei surrounded by a small amount of
cytoplasm and plasma membrane. The
cytoplasts' metabolic activity was demon-
strated by their ability to incorporate
35,330 ct/min of 3H-leucine per 0-1 mg
of protein in acid precipitate, with a very
low DNA synthesis (238 ct/min of [3H]-dT
incorporation per 0-1 mg of protein); the
karyoplasts incorporated 45,149 ct/min
of 3H-leucine per 0-1 mg of protein and
TABLE I.- Yield and characterization of cytoplasts and karyoplasts after enucleation of
Hepatoma D23 cells on a Ficoll gradient in the presence of cytochalasin B
No. ofcells or particles
Recovery (%)
Trypan-blue dye exclusion (%)
Nucleated particles (0% Feulgen staining)
Average density* (g/cm3)
Total protein content (mg)
Mg ofprotein/106 particles
Protein synthesis (3H-leu ct/min/0-lmg protein)
DNA synthesis ([3H]dT ct/min/0 lmg protein)
No. ofFeulgen+ particles/0-lmgprotein
No. oftumorigenic cellst/0-lmg protein 0/o oftumorigenic particles
Input
(whole cells)
4x 107
95
100
1-062
9-93 + 2-77
0-249 + 0-070
230,730
77,530
100
Output
-
Cytoplasts
2-8 + 1-2 x 107
70
99
< 1
1-049
0-29 + 0-13
0-011 + 0-004
35,330
238
760-1500
400-2000
0-004-0-02
Karyoplasts
1-6 + 0-6 x 107
40
50-95
>i 90
1-080
1-98 + 0-91
0-132 + 0-072
75,651
45,149
5,000-15,500
0-7-2-0
* Determined by equlibration sedimentation on a continuous Percoll gradient.
t Determined after i.p. induction of ascites and comparison of the median survival time with that of rats
similarly injected with 104, 103, or 102 untreated Hepatoma D23 cells.
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TABLE II.-Tumour rejection induced by enucleated Hepatoma D23 cell preparations
Immunization* Particles/
with injection
Whole cells
Cytoplasts§
Karyoplasts**
107
106
105
104
2-3 x 107
1.1 X 107
Protein/
injection
(mg)
2*5
0-25
0-025
0-0025
0-26
1-9
Tumour
incidence
12/12
1/18
0/12
6/12
9/9
12/12
1/12
Mean tumour Immuno-
x2 test
(P)
< 0 005
< 0 005
< 0-025
NS
NS
< 0 005
volumet
(mm3 +s.d.)
1827 + 1379
0-17 + 0-75
0
1104+ 1336
3151 + 1986
893 + 758
3-3 + 115
genicity t test
indext (P)
< 0*005
< 0 005
NS
NS
<0*05
< 0*005
1
10,700
(co)
1-7
0 7
2
55
* WAB/Not rats were given i.p. injections of irradiated antigen preparations x 3 at weekly intervals,
followed 1 week later by s.e. challenge with 104 untreated Hepatoma D23 cells.
t Results 21 days after challenge. Tumour volume (mm3) was calculated as 1 x d2 x 0 4, where 1=long
diameter and d=short diameter (see Attia et al., 1965).
t The ratio of mean tumour volume of test rats to mean tumour volume of unimmunized rats (see Law
et al., 1980).
§ Number of whole cells per injection < 5 x 103.
** Number of whole cells per injection < 105.
75,651 ct/min of [3H]dT per 0.1 mg of
protein, these values being lower than the
incorporation by whole D23 cells (230,730
ct/min 3H-leucine and 77,530 ct/min [3H]-
dT). The contamination of the cytoplast
fraction by whole D23 cells was estimated
by the in vivo tumorigenicity assay to be
400-2000 in 01 mg of protein, which
was very similar to the number estimated
from the [3H]-dT incorporation (calcu-
lated as 760-1500 DNA-synthetic par-
ticles in 01 mg of protein). The karyo-
plasts were also contained with 500-
15,500 tumorigenic cells/0 1 mg protein,
corresponding to 1-2% of the nucleated
particles.
Immunogenicity of cytoplasts and
karyoplasts
The results oftwo separate experiments
are detailed in Table II. Three injections
of 2-3 x 107 irradiated cytoplasts (con-
taining 0*26 mg protein) were unable to
protect the animals against a challenge of
104 D23 cells (tumour incidence 12/12)
but significantly delayed tumour growth
(immunogenicityindex 2, 0 05 <P <0.025),
whereas injections of 106 irradiated D23
cells, which were equivalent in protein
content (0-25 mg) were fully protective
(tumour incidence 0/12). In contrast,
immunization with 1-1 x 107 irradiated
karyoplasts protected most of the animals
(tumour incidence 1/12). This protection
was not related to the contaminating
whole cells, since there were < 105 whole
D23 cells per injection and this amount of
immunogen was significantly less protec-
tive (tumour incidence 6/12, P< 0.025)
without tumour-growth retardation (im-
munogenicity index 1 7, P> 0 10).
Ability of cytoplasts to act as a primary
immunogen. Comparison with glutaralde-
hyde- or heat-treated cells and soluble cell
extract
Since cytoplasts alone were only slightly
immunogenic, attempts were made to
use them as a primary immunogen, and to
compare them with other antigenic pre-
parations which have been previously
described as weakly or non-immunogenic
(Dennick et al., 1979; Price et al., 1978,
1979). The general immunization pro-
cedure, which usually gives a consistent
protection with 106 irradiated whole cells,
was modified as follows: the first 2 injec-
tions were performed with the antigen
preparation to be tested and followed by
one injection of 106 irradiated unmodified
D23 cells, before the challenge. The results
of a typical experiment are shown (Table
III). The use of 2-4 x 107 cytoplasts in the
first 2 immunizations was not significantly
protective (tumour incidence 3/6, P >
0-10) but delayed the tumour growth
(immunogenicity index 4, P< 0-0125);
this effect was not as good as 3 injections
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TABLE III.-Ability of cell preparations to act as a primary transplantation immunogen
1st and 2nd injection
Immunization* with
106 IR cells
1070.01% glutaraldehyde-
treated cells
107 0-01% glutaraldehyde-
treated cells
107 43°C heat-treated cells
107 43°C heat-treated cells
2-4 x 107 cytoplasts
3M KCIextract (1 mg of
protein)
3rd Tumour
injection take
6/6
106 IR cells 2/6
106 IR cells 0/6
x2 test
(P)
N.S.
< 0-005
Mean tumour
volume
(mm3 +s.d.)
4537 + 2413
86+ 140
0
6/6 N.S. 3413 + 2809
106 IR cells
106 IR cells
106 IR cells
5/6
3/6
1/6
3/6
N.S.
N.S.
< 0-025
N.S.
2713 + 2123
796 + 1297
0-5+ 1-3
1137 + 1474
106 IR cells 5/6 N.S. 3022+ 2208
Immuno-
genicity t test
index (P)
1
52 < 0-002
(co) < 0-002
1-3 N.S.
1-7 N.S.
5-7 < 0-01o
8728 < 0-002
4-0 <0.01
1-5 N.S.
25
25
25
25
25
* Schedule as described in Table JI.
of 106 cells or even one injection of 106
cells (immunogenicity index 52, P< 0-0025
andtumourincidence 0/6). By comparison,
2 immunizations with 107 0-01% glutar-
aldehyde-treated cells or 1 mg of 3M
KCl soluble-extract protein were unable
to induce a protective effect or tumour-
growth delay when injected alone, and
completely prevented the protective effect
ofa booster injection of 106 untreated cells
(immunogenicity indices 1-7, P> 0-10 and
1-5, P>0-10 respectively). In contrast,
107 430C heat-treated cells were weakly
immunogenic when 2 injections were
given (immunogenicity index 5-7, P<
0-0125) and one booster injection of 106
irradiated cells greatly increased the
immunogenicity of the preparation (tu-
mour incidence 1/6, P<0-025).
Ability of cytoplasts to act as a secondary
immunogen. Comparison with the other
antigenic preparations
The same immunization procedure as
described above was used, except that
rats first received one injection of 106
irradiated D23 cells, followed by 2 injec-
tions of the antigenic preparation to be
tested. Table IV shows the results of a
representative experiment. The injection
of 106 irradiated cells 3 weeks before the
challenge was not protective but sig-
nificantly delayed tumour growth (immu-
nogenicity index 2-4; 0-05<P<0-025),
whereas 3 injections were again fully pro-
tective (tumour incidence 1/6, P < 0-025).
Two injections ofcytoplasts after adminis-
tration of 106 irradiated cells did not pro-
tect the animals but slightly delayed
tumour growth (immunogenicity index
4-3, P< 0-01), but not significantly when
compared with the effect ofthe immuniza-
tion with 106 irradiated cells alone. This
absence of modification on the immuno-
genicity of 106 irradiated cells was also
found when 3M KCI extract or 430C heat-
treated cells were used as a secondary
immunogen. The use of 0-01% glutar-
aldehyde-treated cells was again followed
by the complete prevention of the weak
immunogenicity of 106 irradiated cells
(immunogenicity index 1-8, P > 0-10).
Transplantation immunity after the transfer
ofPECfed with the various antigen
preparations
Since the in vitro incubation of an
antigen with macrophage preparations
before the injection in the animals has
been shown to increase the expression of
its immunogenicity (Brunda & Raffel,
1977), we investigated the effect on the
immunogenicity of the various antigen
preparation after their in vitro feeding to
PEC. As shown in Table V, the only cell
preparation whichwasfully able to protect
the animals against the tumour challenge
after their exposure to 4 x 107 PEC was
the 107 43°C heat treated cells (tumour
incidence 0/6), P< 0-005). The cytoplasts
and 0-01% glutaraldehyde-treated cells
were ineffective either in protecting or
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TABLE IV.-Ability of cell preparations to act as a secondary transplantation immunogen
Mean tumour Immuno-
2nd and 3rd injection I
immunization* with
106 untreated cells
107 0-010% glutaraldehyde-
treated cells
107 0-01% glutaraldehyde-
treated cells
107 43°C heat-treated cells
107 43°C heat-treated cells
2-4 x 107 cytoplasts
3M KCI extract (1 mg ofprotein)
Tumour
take
6/6
1/6
6/6
x2 test
(P)
< 0-025
N.S.
volume
(mm3 +s.d.)
10,950 + 5894
112 + 276
4640 + 3983
6/6 N.S. 8900+ 2386
6/6
2/6
4/6
5/6
4/6
N.S.
N.S.
N.S.
N.S.
N.S.
6183 + 6150
1276 + 1978
3809 + 5206
2541 + 2977
4788 + 3886
genicity
index
1
97
2-4
t test
(P)
< 0-0025
<0-05
1-2 N.S.
1-8
8-6
2-9
4-3
1-9
N.S.
< 0*005
<0-05
< 0-01
<0*05
* Immunization schedule as in Table II.
TABLE V.-Transplantation immunity induced by the transfer of antigen-fed peritoneal-
exudate cells (PEC)
PEC injected
(4 x 107) PEC fed in vitro with
+
+ 106 IR cells
+ 107 0-01% glutaraldehyde-
treated cells
+ 107 43°C heat-treated cells
+ 1-5 x 107 cytoplasts
Tumour
take
6/6
6/6
1/6
6/6
0/6
6/6
x2 test
(P)
N.S.
< 0-025
N.S.
< 0 005
N.S.
Mean tumour
volume
(mm3 +s.d.)
3211 + 3300
4229 + 2443
300 + 734
2724 + 3093
0
3227 + 929
Immuno-
genicity
index
1
0-76
8-9
t test
(P)
N.S.
< 0 05
1-2 N.S.
(co) < 0 005
1 N.S.
4 x 107 PEC were incubated with the irradiated tumour cell preparation for 1 h at 37°C and injected i.p.
into rat. One week later rats were challenged with 104 untreated D23 cells.
delaying the tumour growth (immuno-
genicity index 1; P>040 and 1-2; P>
0 40, respectively) though PEC fed with
only 106 irradiated cells were fully protec-
tive (tumour incidence 1/6, P < 0-025).
DISCUSSION
The data obtained in this study demon-
strate that cytoplasts and karyoplasts
can be isolated after a mass enucleation
of D23 hepatoma cells on a Ficoll gradient
in the presence of cytochalasin B; these
preparations retain partial metabolic acti-
vity, in accordance with previous findings
(Wigler & Weinstein, 1975). The karyo-
plasts were demonstrated to be immuno-
genic in inducing a syngeneic transplanta-
tion tumour resistance. However, karyo-
plasts are only about one tenth as effective
as whole irradiated cells, as determined
by the amount of material required for
full protection, and their immunogenicity
is likely to be due to the presence of
residualcytoplasmandplasmamembranes,
since naked nuclei have been previously
shown to be non-immunogenic (Price &
Baldwin, 1974). In contrast, cytoplasts
induced slight delay ofthe tumour growth.
The low immunogenicity could not be
related to the Ficoll and cytochalasin B
treatment per se, since a sham treatment
of cells did not affect their immuno-
genicity (data not shown), nor to the
reduced amount of material used to im-
munize the animals, since the amount of
protein injected was similar to that of
106 D23 tumour cells, which were sig-
nificantly protective. Moreover, as pre-
viously observed (Berke & Fishelson,
1976; Hale & Paulus, 1979), the cytoplasts
(and karyoplasts) fully expressed the rat
major histocompatibility-complex anti-
gens and the specific serologically defined
D23 antigen (Holmes, personal communi-
cation). Although we have no quantitative
1st
injection
106 IR cells
106 IR cells
106 IR cells
106 IR cells
106 IR cells
106 IR cells
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data, it is unlikely that a modification of
the transplantation antigen expression on
the cytoplasts could explain their low
immunogenicity. Moreover, in another
tumour model, cytoplasts were fully able
to generate specific secondary T cells
during a mixed lymphocyte/tumour-cyto-
plasts culture (Gerlier, in preparation).
Itis more likely that the in vivo persistence
of cytoplasts lacking a nucleus was
strongly reduced, and their probable, fast
degradation did not allow the immune
system to be effectively stimulated. This
can be compared with the loss ofimmuno-
genicity of irradiated D23 cells after their
treatment at 43°C (Dennick et al., 1979):
The cells appeared to be almost unaffected
by this treatment within a few hours
regarding their in vitro metabolic activity
(data not shown) but they were degraded
after 24h in vitro incubation (Dennick
rt al., 1979), this being very similar to the
behaviour of cytoplasts (Wigler & Wein-
stein, 1975). In order to explore further
the weak immunogenicity of the cyto-
plasts, their ability to act as a primary or
a secondary immunogen in association
with a subthreshold dose ofuntreated D23
cells was evaluated, and compared with
that of glutaraldehyde- or heat-treated
cells and soluble KCI- 3M antigenic extract.
The results clearly showed that the cyto-
plasts were unable to enhance the low
immunity induced by 106 untreated cells,
whatever the combination, whereas the
heat-treated cells could at least express
some immunogenicity when injected as a
primary immunogen in combination with
untreated cells. The glutaraldehyde-
treated cells and the 3M KCl-solubilized
antigen were not only unable to act as a
primary or secondary immunogen but
completely suppressed the transplantation
immunity induced by 106 untreated cells.
This complete lack of immunogenicity of
the glutaraldehyde-treated cells agrees
with the work of Milton (1981) who,
showed that glutaraldehyde-treated allo-
geneic cells were unable to be immuno-
genic in a primed animal or to prime for
helper activity (Milton, 1981). Since the
in vivo rapid degradation ofthe cytoplasts
and heat-treated cells could account for
their lack of immunogenicity, we attempt-
ed to resolve this point by in vitro feeding
of non-immune PEC with these prepara-
tions and their transfer to rats. The
association of PEC with the cytoplasts
did not induce any significant transplanta-
tion immunity, though heat-treated cells
fully expressed their immunogenicity. The
glutaraldehyde-treated cells were also not
immunogenic, and it is probable that this
treatment modified the plasma membrane
by inducing heavy cross-linking of the
proteins (data not shown) which became
no longer available for effective macro-
phage processing of antigen (Ramos et al.,
1979). From these studies, it appeared
that in a weakly immunogenic tumour
model the in vivo persistence of the
immunogen is likely to play a crucial role
in inducing resistance to a transplanted
tumour, and that the presence of a
nucleus could be important by stabilizing
the immunogen.
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